These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34369535)

  • 1. Delivery of a system x
    Xin H; Huang Y; Tang H; Chen Y; Xia H; Zhang F; Li B; Ping Y
    J Mater Chem B; 2021 Sep; 9(35):7172-7181. PubMed ID: 34369535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxygen Self-Supplied Perfluorocarbon-Modified Micelles for Enhanced Cancer Photodynamic Therapy and Ferroptosis.
    Ren H; Hao M; Liu G; Li J; Jiang Z; Meng W; Zhang Y
    ACS Appl Bio Mater; 2024 May; 7(5):3306-3315. PubMed ID: 38634490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular Enzyme-Responsive Profluorophore and Prodrug Nanoparticles for Tumor-Specific Imaging and Precise Chemotherapy.
    Pei Q; Lu S; Zhou J; Jiang B; Li C; Xie Z; Jing X
    ACS Appl Mater Interfaces; 2021 Dec; 13(50):59708-59719. PubMed ID: 34879654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
    Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
    Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly Stable Silica-Coated Bismuth Nanoparticles Deliver Tumor Microenvironment-Responsive Prodrugs to Enhance Tumor-Specific Photoradiotherapy.
    Xiang H; Wu Y; Zhu X; She M; An Q; Zhou R; Xu P; Zhao F; Yan L; Zhao Y
    J Am Chem Soc; 2021 Aug; 143(30):11449-11461. PubMed ID: 34292717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
    Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K
    J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Triple-Responsive Polymeric Prodrug Nanoplatform with Extracellular ROS Consumption and Intracellular H
    Li Y; Cao Y; Ma K; Ma R; Zhang M; Guo Y; Song H; Sun N; Zhang Z; Yang W
    Adv Healthc Mater; 2024 Jun; 13(16):e2303568. PubMed ID: 38319010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron ion and sulfasalazine-loaded polydopamine nanoparticles for Fenton reaction and glutathione peroxidase 4 inactivation for enhanced cancer ferrotherapy.
    Zhu X; Chen Q; Xie L; Chen W; Jiang Y; Song E; Song Y
    Acta Biomater; 2022 Jun; 145():210-221. PubMed ID: 35470077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traceable Nanocluster-Prodrug Conjugate for Chemo-photodynamic Combinatorial Therapy of Non-small Cell Lung Cancer.
    Srinivasulu YG; Mozhi A; Goswami N; Yao Q; Xie J
    ACS Appl Bio Mater; 2021 Apr; 4(4):3232-3245. PubMed ID: 35014410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemodynamic therapy combined with endogenous ferroptosis based on "sea urchin-like" copper sulfide hydrogel for enhancing anti-tumor efficacy.
    Li S; Wang B; Tao J; Dong Y; Wang T; Zhao X; Jiang T; Zhang L; Yang H
    Int J Pharm; 2024 Jul; 660():124330. PubMed ID: 38866081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Tumor-Activated Prodrug Strategy Targeting Ferrous Iron Is Effective in Multiple Preclinical Cancer Models.
    Spangler B; Fontaine SD; Shi Y; Sambucetti L; Mattis AN; Hann B; Wells JA; Renslo AR
    J Med Chem; 2016 Dec; 59(24):11161-11170. PubMed ID: 27936709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyoxometalate Modified by Zeolite Imidazole Framework for the pH-Responsive Electrodynamic/Chemodynamic Therapy.
    Song Y; Sun Y; Tang M; Yue Z; Ni J; Zhao J; Wang W; Sun T; Shi L; Wang L
    ACS Appl Mater Interfaces; 2022 Feb; 14(4):4914-4920. PubMed ID: 35050579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Paclitaxel Prodrug Activatable by Irradiation in a Hypoxic Microenvironment.
    Zhou S; Hu X; Xia R; Liu S; Pei Q; Chen G; Xie Z; Jing X
    Angew Chem Int Ed Engl; 2020 Dec; 59(51):23198-23205. PubMed ID: 32852145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A homologous membrane-camouflaged self-assembled nanodrug for synergistic antitumor therapy.
    Xie X; Li Z; Tang H; Zhang Y; Huang Y; Zhang F; You Y; Xu L; Wu C; Yao Z; Peng X; Zhang Q; Li B
    Acta Biomater; 2024 Jul; 183():292-305. PubMed ID: 38838903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irinotecan delivery by unimolecular micelles composed of reduction-responsive star-like polymeric prodrug with high drug loading for enhanced cancer therapy.
    Gao YE; Bai S; Shi X; Hou M; Ma X; Zhang T; Xiao B; Xue P; Kang Y; Xu Z
    Colloids Surf B Biointerfaces; 2018 Oct; 170():488-496. PubMed ID: 29960949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoferrocene-based prodrugs activated by reactive oxygen species.
    Hagen H; Marzenell P; Jentzsch E; Wenz F; Veldwijk MR; Mokhir A
    J Med Chem; 2012 Jan; 55(2):924-34. PubMed ID: 22185340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Azidobenzyl ferrocenylcarbamate as an anticancer prodrug activated under reductive conditions.
    Kinski E; Marzenell P; Hofer W; Hagen H; Raskatov JA; Knaup KX; Zolnhofer EM; Meyer K; Mokhir A
    J Inorg Biochem; 2016 Jul; 160():218-24. PubMed ID: 26970945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction-Responsive Chemo-Capsule-Based Prodrug Nanogel for Synergistic Treatment of Tumor Chemotherapy.
    Lu Y; Jia D; Ma X; Liang M; Hou S; Qiu W; Gao Y; Xue P; Kang Y; Xu Z
    ACS Appl Mater Interfaces; 2021 Feb; 13(7):8940-8951. PubMed ID: 33565847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manganese-deposited iron oxide promotes tumor-responsive ferroptosis that synergizes the apoptosis of cisplatin.
    Cheng J; Zhu Y; Xing X; Xiao J; Chen H; Zhang H; Wang D; Zhang Y; Zhang G; Wu Z; Liu Y
    Theranostics; 2021; 11(11):5418-5429. PubMed ID: 33859755
    [No Abstract]   [Full Text] [Related]  

  • 20. A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy.
    Chen Y; Yao Z; Liu P; Hu Q; Huang Y; Ping L; Zhang F; Tang H; Wan T; Ping Y; Li B
    Acta Biomater; 2023 Mar; 159():275-288. PubMed ID: 36709836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.